Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjive Qazi

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Ebiomedicine|July 12, 2016
Realizing the Potential for Recipient Immune Cells in Adoptive Immune TherapySanjive Qazi
International Journal of Molecular Sciences|October 26, 2024
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal AdenocarcinomaSanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences|June 28, 2023
Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival OutcomesFatih M Uckun, Sanjive Qazi
Expert Opinion on Therapeutic Patents|September 14, 2010
Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunityFatih M Uckun, Sanjive Qazi
Haematologica|December 11, 2013
Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemiaSanjive Qazi, Fatih M Uckun
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistanceFatih M Uckun, Sanjive Qazi
Journal of Personalized Medicine|May 27, 2023
Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival OutcomeSanjive Qazi, Fatih M Uckun
Expert Review of Anticancer Therapy|September 15, 2010
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomasFatih M Uckun, Sanjive Qazi
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2019
Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomasFatih M Uckun, Sanjive Qazi
British Journal of Haematology|April 10, 2010
Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsetsSanjive Qazi, Fatih M Uckun
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Ebiomedicine|July 12, 2016
Realizing the Potential for Recipient Immune Cells in Adoptive Immune TherapySanjive Qazi
International Journal of Molecular Sciences|October 26, 2024
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal AdenocarcinomaSanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences|June 28, 2023
Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival OutcomesFatih M Uckun, Sanjive Qazi
Expert Opinion on Therapeutic Patents|September 14, 2010
Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunityFatih M Uckun, Sanjive Qazi
Haematologica|December 11, 2013
Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemiaSanjive Qazi, Fatih M Uckun
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistanceFatih M Uckun, Sanjive Qazi
Journal of Personalized Medicine|May 27, 2023
Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival OutcomeSanjive Qazi, Fatih M Uckun
Expert Review of Anticancer Therapy|September 15, 2010
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomasFatih M Uckun, Sanjive Qazi
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2019
Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomasFatih M Uckun, Sanjive Qazi
British Journal of Haematology|April 10, 2010
Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsetsSanjive Qazi, Fatih M Uckun
Pageof 9